Hydrochloric Acid

Hydrochloric Acid

SCHEMBL996361

CCN1CCOCC1.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL27976015 0.97 GAA (0.42)
SCHEMBL15265769 0.97 USP2 (0.46)
Fluoride SCHEMBL7750159 0.97
SCHEMBL474212 0.97
SCHEMBL3167 0.97
SCHEMBL28231022 0.97 USP2 (0.46)
Fluoride SCHEMBL11426086 0.97 USP2 (0.46)
SCHEMBL8135220 0.97
SCHEMBL23481366 0.94 ALDH1A1 (0.48)
SCHEMBL15266433 0.94 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105228606-A Composition of alpha-2 adrenergic receptor and sigma receptor ligand ESTEVE LABOR DR 2016-01-06 CN claimed
CN-103052388-A Use of sigma ligands in opioid-induced hyperalgesia ESTEVE LABOR DR 2013-04-17 CN claimed
CN-1160331-C Process for preparing photoactivated (-) yellow skin amide 中国医学科学院药物研究所 2004-08-04 CN claimed
CN-1345721-A Process for preparing photoactivated (-) yellow skin amide PHARMACEUTICAL INST CHINESE AC (CN) 2002-04-24 CN claimed
US-5203986-A Solution containing oxidizer and complexing agent NKK CORPORATION (JP) 1993-04-20 US claimed
US-4873364-A THERMAL DECOMPOSITION OF THE CORRESPONDING UREA IN THE PRESENCE OF A TERTIARY AMINE HYDROHALIDE ARCO CHEMICAL TECHNOLOGY, INC. (US) 1989-10-10 US claimed
WO-2025099241-A1 NLRP3 MODULATORS EVOTEC INTERNATIONAL GMBH (DE) 2025-05-15 WO disclosed
EP-4304554-A1 DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES Aquestive Therapeutics, Inc. (US) 2024-01-17 EP disclosed
CN-113795239-B Topical composition 帝斯曼知识产权资产管理有限公司 2023-10-13 CN disclosed
CN-116023321-A STING inhibitor prodrug and medical application thereof 中国药科大学 2023-04-28 CN disclosed
CN-109875906-B Corrosion-resistant reinforcing agent 帝斯曼知识产权资产管理有限公司 2023-03-31 CN disclosed
CN-110831564-B Topical compositions 帝斯曼知识产权资产管理有限公司 2023-01-31 CN disclosed
CN-110831570-B New use 帝斯曼知识产权资产管理有限公司 2022-10-18 CN disclosed
EP-0402020-A1 An integrated process for the preparation of methylene diphenylene diisocyanates and polymethylene polyphenylene poly (isocyanates) from diamines and polyamines ARCO CHEMICAL TECHNOLOGY, INC. (US) 1990-12-12 EP disclosed
EP-0167152-B1 PROTEASE ADSORBENT AND PROCESS FOR PURIFYING TPA UTILIZING THE SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1990-11-14 EP disclosed
US-4708944-A Protease adsorbent and process for purifying TPA utilizing the same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1987-11-24 US disclosed
EP-0167152-A2 Protease adsorbent and process for purifying TPA utilizing the same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1986-01-08 EP disclosed
US-4401594-A PROTEOLYTIC ENZYME INHIBIJTORS; CARDIOVASCULAR AND MUSCULAR DISORDERS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1983-08-30 US disclosed
US-4326009-A Polymeric particulate carrier ROYER GARFIELD P 1982-04-20 US disclosed
US-4238481-A HYPOGLYCEMIC AGENT; HYPERGLYCEMIC AGENT; ANIMAL GROWTH REGULATOR CIBA-GEIGY CORPORATION (US) 1980-12-09 US disclosed